[1]
Ali, R.M., Kakamad, F.H., Abdullah, H.O., Abdulla, S.H., Ahmed, S.F., Bnar J. Hama Amin, Marwan N. Hassan, Hasan, S.J., Hussein M. Hamasalih, Berun A. Abdalla, Rawezh Q. Salih and Hawbash M. Rahim 2023. Pembrolizumab (Anti-PD-1) in the management of malignant pleural mesothelioma: A systematic review of the current literature. Barw Medical Journal. (Jun. 2023). DOI:https://doi.org/10.58742/bmj.v1i2.34.